Nandita Khera, M.D., M.P.H.

  1. Hematologist
  2. Internist
  3. Oncologist

Departamentos

Grupos especializados

Location

  1. Phoenix, Arizona

Idiomas

English
  • Late effects after hematopoietic cell transplantation
  • Heme malignancies
  • Health economics
  • Outcomes research in stem cell transplant
Phx

Phoenix, Arizona

  1. 2012
    Masters - Public HealthUniversity of Washington
  2. 2011
    Fellow - Hematology-OncologyUniversity of Washington
  3. 2008
    Internship/Residency - Internal MedicineTemple University Campus, Western Pennsylvania Hospital
  4. 2005
    Research AssociateChildren's Hospital of Pittsburgh
  5. 2004
    Junior Resident - Clinical PharmacologyAll India Institute of Medical Sciences Hospital
  6. 2002
    Junior Resident - Forensic Medicine and ToxicologyLady Hardinge Medical College
  7. 2000
    MB BSLady Hardinge Medical College

Certifications

  1. 2012
    Medical OncologyAmerican Board of Internal Medicine
  2. 2011
    HematologyAmerican Board of Internal Medicine

Awards and honors

  1. 2017
    Kern Scholar AwardRobert D. and Patricia E. Kern Center for the Science of Healthcare Delivery
  2. 2010
    Tuition Support Fellowship for MPH in Health ServicesInstitute of Translational Health Sciences

Professional memberships

  1. 2022 - present
    Director of Community or Clinical PracticeAmerican Society of Transplantation and Cellular Therapy (ASTCT)
  2. 2022 - 2023
    Faculty At-LargeCurriculum Committee, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic Arizona Committees
  3. 2020
    MemberSOSS Late Effects Committee, Bone and Marrow Transplant Clinical Trials Network (BMT CTN)
  4. 2020
    MemberPublic Health Committee, Arizona Medical Association
  5. 2020 - present
    Associate ChairDigital Transformation and Practice, Department of Medicine
  6. 2020 - present
    Medical DirectorAmbulatory Infusion Center, Department of Hematology/Oncology, Mayo Clinic in Arizona
  7. 2019 - present
    ChairEvidence into Practice Task Force, Bone and Marrow Transplant Clinical Trials Network (BMT CTN)
  8. 2018 - 2020
    MemberSpecial Populations Committee, Bone and Marrow Transplant Clinical Trials Network (BMT CTN)
  9. 2018
    ChairAdvisory Group on Financial Barriers to Transplant, National Marrow Donor Program
  10. 2018
    MemberLate Effects Task Force, Center for International Blood and Marrow Transplant Research (CIBMTR)
  11. 2017
    Vice ChairAdvisory Group on Financial Barriers to Transplant, National Marrow Donor Program
  12. 2017 - present
    MemberStudent Promotions and Assessment Review Committee, Mayo Clinic Alix School of Medicine - Arizona, Mayo Clinic College of Medicine and Science
  13. 2016
    MemberTask Force for Choosing Wisely BMT Committee, American Society for Blood and Marrow Transplantation/Canadian Blood and Marrow Transplant Group
  14. 2016 - present
    MemberCancer Center Research Committee, Research Operations Management Team, Executive Operations Team - Arizona
  15. 2016 - present
    MemberMortality Review Subcommittee, Clinical Practice Quality Oversight Subcommittee, Executive Operations Team - Arizona
  16. 2015 - 2020
    Co-ChairHealth Services and International Issues Working Committee, Center for International Blood and Marrow Transplant Research (CIBMTR)
  17. 2015 - present
    MemberAdvisory Group on Financial Barriers to Transplant, National Marrow Donor Program
  18. 2013 - 2017
    Medical DirectorHealth Equity Research Initiative Program, Mayo Clinic Arizona Committees
  19. 2013
    MemberSOSS Late Effects Committee, Bone and Marrow Transplant Clinical Trials Network (BMT CTN)
  20. 2010 - present
    MemberAmerican Society for Blood and Marrow Transplantation
  21. 2010 - present
    Associate MemberAmerican Society of Clinical Oncology
  22. 2009 - present
    MemberAmerican Society of Hematology